Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 0 | 0 | 0 | 1,000 |
| Gross Profit | N/A | N/A | N/A | N/A | 1,000 |
| Operating Expenses | 48,023 | 49,855 | 48,221 | 42,618 | 35,438 |
| Operating Income | -48,023 | -49,855 | -48,221 | -42,618 | -34,438 |
| Other Income | 371 | 664 | 1,202 | 1,687 | 2,087 |
| Pre-tax Income | -47,652 | -49,191 | -47,019 | -40,931 | -32,351 |
| Net Income Continuous | -47,652 | -49,191 | -47,019 | -40,931 | -32,351 |
| Net Income | $-47,652 | $-49,191 | $-47,019 | $-40,931 | $-32,351 |
| EPS Basic Total Ops | -2.03 | -2.34 | -2.25 | -1.96 | -1.55 |
| EPS Basic Continuous Ops | -2.03 | -2.34 | -2.25 | -1.96 | -1.55 |
| EPS Diluted Total Ops | -2.03 | -2.34 | -2.25 | -1.96 | -1.55 |
| EPS Diluted Continuous Ops | -2.03 | -2.34 | -2.25 | -1.96 | -1.55 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.34 | -2.25 | -1.96 | -1.30 |
| EBITDA(a) | $-47,574 | $-49,412 | $-47,974 | $-42,422 | $-34,066 |